Latest Regulatory Approval News

Race Oncology has secured Investigational New Drug approval from South Korea’s regulatory authority, enabling Phase 1 clinical trials of RC220 in combination with doxorubicin for solid tumour patients across four Korean sites.

Jade Gas Holdings has secured a landmark five-year LNG sales agreement with UB Metan LLC, Mongolia’s largest natural gas importer, marking a pivotal step in its South Gobi coal bed methane project development.

Tuas Limited has reported a robust turnaround in FY25 with positive net profit and strong subscriber growth, alongside completing the strategic acquisition of M1 Limited. The company sets sights on further expansion amid regulatory review.

Tuas Limited delivered a strong turnaround in FY25 with a 29% revenue increase and a return to profitability, while announcing a conditional acquisition of Singapore’s M1 Limited that could reshape its market position.

Brookside Energy has announced a new Area of Interest in the Anadarko Basin, targeting thick, liquids-rich reservoirs with promising economic returns and significant reserves growth potential.

Micro-X Ltd has secured a $4.4 million Australian Government grant to develop and trial a portable Head CT scanner designed for standard ambulances, aiming to transform emergency stroke care with faster diagnosis and treatment.

Forrestania Resources has agreed to acquire four exploration licences adjacent to the Edna May Gold Mine, aiming to strengthen its position in Western Australia's Southern Cross region.

Bio-Gene Technology’s novel acaricide Flavocide demonstrated over 90% mortality against Lyme disease-carrying ticks in lab tests presented by Purdue University, highlighting its potential in public health applications.

Arovella Therapeutics has received a $3.21 million R&D tax incentive refund, bolstering its financial position as it prepares to initiate first-in-human trials for its lead cell therapy, ALA-101.

Clover Corporation posted a robust 38% revenue increase to $86 million in FY25, driven by product innovation and operational gains, while declaring a final dividend. The company’s cautious outlook for FY26 reflects ongoing regulatory and production challenges.

Australian Critical Minerals has completed its acquisition of Circuit Resources, securing a 25,600-hectare portfolio in Peru rich in precious and base metals, with multiple drill-ready projects poised for exploration.

Memphasys Limited has secured $0.84 million through a placement and announced a rights issue to raise up to $1.12 million, sharply cutting operating costs to accelerate commercialisation and manufacturing scale-up of its Felix™ bioseparation system.